| Autor: |
N B, Haas, J, Manola, G, Hudes, D L, Citrin, M S, Kies, T E, Davis |
| Rok vydání: |
2001 |
| Předmět: |
|
| Zdroj: |
American journal of clinical oncology. 23(6) |
| ISSN: |
0277-3732 |
| Popis: |
Twenty-nine patients with progressive hormone-refractory metastatic adenocarcinoma of the prostate were treated with daily estramustine phosphate at 10 mg/kg, and I.V. doxorubicin 50 mg/m2 every 3 weeks. Twenty-six patients were evaluable. Four of seven patients with nonosseous measurable disease had partial responses lasting 3 to 10 months. Eleven of 19 patients with osseous metastases had stable disease or improvement on bone scan, 6 of these for 7 months or longer. Median time to progression was 20 weeks, and the median survival was 43 weeks. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
